Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to: Response to the Letter to the Editor by Koneswarakantha and Ménard.

Autor: Janitza, Silke¹ (AUTHOR), Majumder, Madhurima² (AUTHOR), Mendolia, Franco³ (AUTHOR) franco.mendolia@bayer.com, Jeske, Steffen⁴ (AUTHOR), Kulmann, Hermann¹ (AUTHOR)

Publikováno v: Therapeutic Innovation & Regulatory Science. May2022, Vol. 56 Issue 3, p381-381. 1p.

HORMONE REPLACEMENT THERAPY METHOD AND ITS ADMINISTRATION FORM

Autor: SCHERING AG, KULMANN HERMANN

Method for hormone replacement therapy, in which at least in the established postmenopause a daily unit with at least one hormonal component, namely with at least estrogen (E) and/or at least one gestagen (G) is administered permanently and continuou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=epopatstat__::e673c6740f8b300ddd9018c4effc7090
https://register.epo.org/application?number=EP0200089

A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.

Autor: Muysers C; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Dmitrienko A; 2 Mediana Inc, Overland Park, KS, USA., Kulmann H; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Kirsch B; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Lippert S; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Schmelter T; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Schulz A; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Mentenich N; 1 Statistics and Data Insights, Bayer AG, Berlin/Wuppertal, Germany., Schmitz H; 3 Clinical Development, Bayer AG, Berlin, Germany., Schaefers M; 3 Clinical Development, Bayer AG, Berlin, Germany., Meinhardt G; 4 Clinical Development Oncology, Bayer AG, Whippany, NJ, USA., Keil T; 5 Institute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin, Berlin, Germany., Roll S; 5 Institute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin, Berlin, Germany.

Publikováno v: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2019 Jun 16, pp. 2168479019853782. Date of Electronic Publication: 2019 Jun 16.